Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1179392 NEW YORK, NY
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$71,980
-$67,984 QoQ
Shares Held
54,947
-38.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 130 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. LCTX ranks #323 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in LCTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,980 54,947
2026-03-31 $139,964 88,585
2025-12-31 $443,526 265,585
2025-09-30 $598,846 354,347
2025-06-30 $289,359 317,977
2025-03-31 $216,190 480,423
2024-12-31 $150,772 301,544
2023-06-30 $115,360 81,816
2023-03-31 $37,959 25,306
2022-12-31 $35,874 30,662
2021-12-31 $1,325,018 540,824
2021-09-30 $1,463,585 580,788
2021-06-30 $3,746,515 1,314,567
2021-03-31 $2,948,147 1,254,531
2020-12-31 $963,098 547,215
2020-09-30 $197,404 210,005
2020-06-30 $286,178 328,941
2020-03-31 $134,985 162,633